🔗 Share this article

The top legal official in Texas Paxton is suing the producers of Tylenol, alleging the companies withheld safety concerns that the medication presented to pediatric cognitive development.

This legal action follows a month after President Donald Trump promoted an unsubstantiated connection between consuming acetaminophen - alternatively called acetaminophen - throughout gestation and autism spectrum disorder in children.

The attorney general is filing suit against J&J, which previously sold the medication, the sole analgesic approved for pregnant women, and the current manufacturer, which currently produces it.

In a declaration, he stated they "betrayed America by making money from discomfort and pushing pills ignoring the dangers."

The manufacturer says there is lacking scientific proof linking acetaminophen to autism.

"These corporations deceived for years, deliberately risking numerous people to line their pockets," the attorney general, from the Republican party, declared.

The company stated officially that it was "deeply concerned by the perpetuation of misinformation on the reliability of paracetamol and the potential impact that could have on the health of American women and children."

On its website, Kenvue also stated it had "continuously evaluated the applicable studies and there is lacking reliable evidence that shows a proven link between consuming paracetamol and autism spectrum disorder."

Organizations acting on behalf of doctors and healthcare providers agree.

ACOG has declared paracetamol - the primary component in Tylenol - is among limited choices for pregnant women to manage pain and fever, which can pose significant medical dangers if not addressed.

"In multiple decades of investigation on the use of acetaminophen in gestation, zero credible investigations has successfully concluded that the consumption of paracetamol in any period of pregnancy results in neurodevelopmental disorders in offspring," the group commented.

This legal action cites recent announcements from the previous government in claiming the medication is reportedly hazardous.

In recent weeks, Trump generated worry from public health officials when he told expectant mothers to "resist strongly" not to take acetaminophen when unwell.

The FDA then released a statement that medical professionals should consider limiting the consumption of acetaminophen, while also mentioning that "a proven link" between the medication and autism spectrum disorder in children has not been proven.

Health Secretary Kennedy, who supervises the Food and Drug Administration, had promised in April to undertake "comprehensive study program" that would determine the origin of autism spectrum disorder in a matter of months.

But specialists advised that finding a single cause of autism - thought by researchers to be the result of a complicated interplay of genetic and surrounding conditions - would prove challenging.

Autism spectrum disorder is a category of enduring cognitive variation and impairment that impacts how individuals experience and engage with the surroundings, and is identified using physician assessments.

In his court filing, the attorney general - who supports Trump who is running for the Senate - claims the manufacturer and J&J "intentionally overlooked and attempted to silence the science" around acetaminophen and autism spectrum disorder.

The case aims to force the companies "remove any promotional materials" that asserts acetaminophen is safe for pregnant women.

The court case parallels the complaints of a group of parents of children with autism spectrum disorder and ADHD who filed suit against the manufacturers of Tylenol in 2022.

Judicial authorities dismissed the legal action, declaring studies from the plaintiffs' authorities was not conclusive.